Hospital vs. Cell Phone Number Follow-Up Randomization Study (FURS)
|ClinicalTrials.gov Identifier: NCT01620827|
Recruitment Status : Completed
First Posted : June 15, 2012
Last Update Posted : August 19, 2016
|Condition or disease||Intervention/treatment||Phase|
|Subject Follow-up||Other: Hospital Landline Phone Calls Other: Private Cell Phone Calls||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||400 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Study Subject Responsiveness to Follow-Up Phone Calls From a Hospital Landline as Compared With From a Private Cellular Phone Number|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||July 2013|
Active Comparator: Hospital Landline
Subjects in this arm have all of their follow-up phone calls placed from a hospital landline number.
Other: Hospital Landline Phone Calls
Follow-up phone calls are made from the hospital landline phones in a research office
Active Comparator: Private Cell Phone
Subjects in this arm have all of their follow-up phone calls placed from a private cell phone number.
Other: Private Cell Phone Calls
Follow-up phone calls are made from the private cell phones of research assistants
- Successful phone call contact at 30 days [ Time Frame: 90 days ]Contact is attempted from 30 days after enrollment through 90 days after enrollment. If contact is made during this time frame, 30 day follow-up is considered to have been successful.
- The number of call attempts required to obtain successful follow-up [ Time Frame: 90 days ]Contact is attempted from 30 days after enrollment through 90 days after enrollment. The number of calls required to make successful contact in this time frame are recorded.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01620827
|United States, Pennsylvania|
|Hospital of the University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|
|Principal Investigator:||Judd Hollander, MD||University of Pennsylvania|